Clinical Trials: Alimta to Treat Malignant Pleural Mesothelioma
Get a free copy of our sourcebook, "Mesothelioma, Lung Cancer, Asbestos Litigation And Your Rights."
Asbestos is a known carcinogen, and exposure to asbestos is known to cause serious diseases such as mesothelioma, asbestos-related lung cancer and asbestosis.
According to a study published by the Food and Drug Administration (FDA), in clinical trials patients who were treated with Alimta and cisplatin had a median survival of 12.1 months compared to 9.3 months for patients treated with cisplatin alone.
Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease. If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.

Alimta for the treatment of lung tumors and asbestos-related cancers